Growing geriatric population suffering from various diseases is expected to drive the growth of global drug discovery informatics market
According to TechSci Research report, “Global Drug Discovery Informatics Market By Component (Software v/s Service), By Function (Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, Clinical Trial Data Management, Others), By Mode (In-house Informatics v/s Outsourced), By Application (Drug Discovery v/s Drug Development), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Others), By Region, Forecast & Opportunities, 2025”, the global drug discovery informatics market is expected to grow at a formidable rate during the forecast period on account of the growing prevalence of infectious, chronic and rare diseases. Additionally, the sudden outbreak and spread of pandemic COVID-19, which has adversely impacted the world with no available treatment or medicine available, is expected to positively influence the market growth through 2025. Furthermore, improving healthcare IT infrastructure is further expected to spur the market growth during the forecast period. Besides, use of advanced technologies such as machine learning, bioinformatics, AI, blockchain, among others in drug discovery is further expected to create lucrative opportunities for the market growth until 2025. Moreover, increasing R&D activities for novel molecule discovery is expected to propel the market growth over the next few years. However, high cost of use and deployment of informatics software might hamper the market growth during the forecast period. Also, the dearth of skilled professionals might further impede the market growth.
Browse XX market data Tables and XX Figures spread throughXX Pages and an in-depth TOC on “Global Drug Discovery Informatics Market”
https://www.techsciresearch.com/report/drug-discovery-informatics-market/4957.html
The global drug discovery Informatics market is segmented based on component, function, mode, application, end user, company and region. Based on Based on function, the market can be fragmented into sequencing and target data analysis, docking, molecular modelling, library & database preparation, clinical trial data management and others. Among these, the sequencing and target analysis segment is expected to dominate the market. This can be ascribed to the increased application for sequencing analysis for the new drug entities and ease of handling of information from different sources. Based on mode, the market can be bifurcated into in-house informatics and outsourced. Here, the outsourced segment is expected to hold a significant market share owing to the associated benefits such as access to advanced & innovative technologies, increased production, shorter timelines, reduced risks, focus on core competencies, among others. Based on end user, the market can be fragmented into pharmaceutical companies, biotechnology companies, contract research organization (CROs) and others. Among these, the pharmaceutical companies are projected to hold the largest market share on account of the widespread use of informatics software for research and development of drugs.
Jubilant Life Sciences Limited, IBM Corporation, Clarivate Analytics, Eurofins Scientific, Thermo Fisher Scientific, Accenture PLC, PerkinElmer Inc, Schrödinger, Inc., Certara L.P., Evotec AG and others are some of the leading players operating in global drug discovery informatics market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4957
Customers can also request for 10% free customization on this report.
“North America is expected to dominate the drug discovery informatics market during the forecast period, owing to the prevalence of various chronic diseases such as diabetes, cancer, CVD, among others in the region. Furthermore, presence of major market players in the region along with well-established CROs is expected to fuel the market growth through 2025. Additionally, increasing investments by major biopharmaceutical and biotechnology companies coupled with new product launches is expected to create lucrative opportunities for the market growth during the forecast period.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Drug Discovery Informatics Market By Component (Software v/s Service), By Function (Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, Clinical Trial Data Management, Others), By Mode (In-house Informatics v/s Outsourced), By Application (Drug Discovery v/s Drug Development), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Others), By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global drug discovery informatics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global drug discovery informatics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]